Related Experiment Videos

Pharmacokinetics of lignocaine in children following caudal anaesthesia

Insights

This study investigated lignocaine plasma concentrations in children after caudal anesthesia. Results show a longer elimination half-life in children, likely due to a larger volume of distribution.

Area of Science:

  • Pediatric Anesthesiology
  • Clinical Pharmacology

Background:

  • Lidocaine (lignocaine) is commonly used for local anesthesia.
  • Understanding its pharmacokinetics in pediatric populations is crucial for safe and effective dosing.

Purpose of the Study:

  • To determine the pharmacokinetic profile of lignocaine following caudal anesthesia in children.
  • To compare pediatric pharmacokinetic parameters with those reported in adults.

Main Methods:

  • 11 healthy children (3.5-9 years) received caudal anesthesia with 5 mg/kg lignocaine.
  • Plasma lignocaine concentrations were measured for up to 6 hours post-administration.
  • Pharmacokinetic analysis was performed using a two-compartmental model.

Main Results:

  • Peak plasma lignocaine concentration was 2.05 ± 0.08 µg/mL at 28.2 ± 2.9 minutes.
  • The elimination half-life was significantly longer in children (155 ± 32 min) compared to adults.
  • Total body clearance was similar to adults (15.4 ± 1.2 mL/min/kg).

Conclusions:

  • The longer elimination half-life in children is attributed to a larger volume of distribution (3.05 ± 0.40 L/kg).
  • These findings are essential for optimizing lignocaine dosing strategies in pediatric caudal anesthesia.

Related Concept Videos